Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications
- PMID: 30045197
- DOI: 10.1097/AOG.0000000000002769
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications
Comment in
-
In Reply.Obstet Gynecol. 2018 Aug;132(2):519-520. doi: 10.1097/AOG.0000000000002770. Obstet Gynecol. 2018. PMID: 30045198 No abstract available.
Comment on
-
Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.Obstet Gynecol. 2018 Apr;131(4):642-651. doi: 10.1097/AOG.0000000000002521. Obstet Gynecol. 2018. PMID: 29528920
References
-
- Desai VB, Wright JD, Schwartz PE, Jorgensen EM, Fan L, Litkouhi B, et al. Occult gynecologic cancer in women undergoing hysterectomy or myomectomy for benign indications. Obstet Gynecol 2018;131:642–51.
-
- Jamison PM, Altekruse SF, Chang JT, Zahn J, Lee R, Noone AM, et al. Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2. Cancer 2014;120(suppl 23):3836–45.
-
- Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, et al. Management of uterine fibroids. Comparative Effectiveness Review No. 195. AHRQ Publication No. 17(18)-EHC028-EF. Rockville (MD): Agency for Healthcare Research and Quality; 2017.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical